Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results.

Myocardial infarction (MI) is the leading cause of death in Iran. Every attempt to improve treatment patterns and patient outcomes needs a surveillance system to both consider the efficacy and safety measures. Fasa Registry on Myocardial Infarction (FaRMI) is the first population-based registry for...

Full description

Bibliographic Details
Main Authors: Ehsan Bahramali, Alireza Askari, Habib Zakeri, Mojtaba Farjam, Azizallah Dehghan, Kazem Zendehdel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5132161?pdf=render
id doaj-777b10b6ff164ad2ae2d5ae663a4c6a2
record_format Article
spelling doaj-777b10b6ff164ad2ae2d5ae663a4c6a22020-11-25T00:08:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011112e016757910.1371/journal.pone.0167579Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results.Ehsan BahramaliAlireza AskariHabib ZakeriMojtaba FarjamAzizallah DehghanKazem ZendehdelMyocardial infarction (MI) is the leading cause of death in Iran. Every attempt to improve treatment patterns and patient outcomes needs a surveillance system to both consider the efficacy and safety measures. Fasa Registry on Myocardial Infarction (FaRMI) is the first population-based registry for acute MI in Iran targeted to provide meticulous description of patients' characteristics, to explore the management patterns of these patients, to discover the degree of adherence to the practice guidelines, and to investigate the determinants of poor in-hospital and later outcomes.A diagnosis of acute MI (type I, II and III) was made upon the accepted criteria by the attending cardiologists and types IV and V MI were excluded. Two registrar nurses gathered data on demographics, place of residence and ethnicity, past medical history, risk factors, and the clinical course. Management patterns in the pre-hospital setting, during the hospital stay and at the discharge time were recorded. Routine laboratory results and cardiac biomarkers on three consecutive days were registered.pilot phase included the first 95 patients, 63.5% of whom were men and 31.5% were women. With a mean age of 62.89±13.75 years among participants, the rate of premature MI was 31.8%. ST segment elevation MI accounted for 68.2% cases and inferior wall was the most prevalent region involved followed by anterior and posterior walls.Obtained data on the characteristics of patients suffering an MI event revealed the major determinants of delay in initiation of therapies and contributors of poor outcome. Completeness of data was guaranteed upon involvement of multiple checkpoints and data quality was secured by means of automatic validation processes in addition to weekly physicians' roundups.Execution of FaRMI in the form presented is feasible and it will build up a comprehensive population-based registry for MI in the region.http://europepmc.org/articles/PMC5132161?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ehsan Bahramali
Alireza Askari
Habib Zakeri
Mojtaba Farjam
Azizallah Dehghan
Kazem Zendehdel
spellingShingle Ehsan Bahramali
Alireza Askari
Habib Zakeri
Mojtaba Farjam
Azizallah Dehghan
Kazem Zendehdel
Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results.
PLoS ONE
author_facet Ehsan Bahramali
Alireza Askari
Habib Zakeri
Mojtaba Farjam
Azizallah Dehghan
Kazem Zendehdel
author_sort Ehsan Bahramali
title Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results.
title_short Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results.
title_full Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results.
title_fullStr Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results.
title_full_unstemmed Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results.
title_sort fasa registry on acute myocardial infarction (farmi): feasibility study and pilot phase results.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Myocardial infarction (MI) is the leading cause of death in Iran. Every attempt to improve treatment patterns and patient outcomes needs a surveillance system to both consider the efficacy and safety measures. Fasa Registry on Myocardial Infarction (FaRMI) is the first population-based registry for acute MI in Iran targeted to provide meticulous description of patients' characteristics, to explore the management patterns of these patients, to discover the degree of adherence to the practice guidelines, and to investigate the determinants of poor in-hospital and later outcomes.A diagnosis of acute MI (type I, II and III) was made upon the accepted criteria by the attending cardiologists and types IV and V MI were excluded. Two registrar nurses gathered data on demographics, place of residence and ethnicity, past medical history, risk factors, and the clinical course. Management patterns in the pre-hospital setting, during the hospital stay and at the discharge time were recorded. Routine laboratory results and cardiac biomarkers on three consecutive days were registered.pilot phase included the first 95 patients, 63.5% of whom were men and 31.5% were women. With a mean age of 62.89±13.75 years among participants, the rate of premature MI was 31.8%. ST segment elevation MI accounted for 68.2% cases and inferior wall was the most prevalent region involved followed by anterior and posterior walls.Obtained data on the characteristics of patients suffering an MI event revealed the major determinants of delay in initiation of therapies and contributors of poor outcome. Completeness of data was guaranteed upon involvement of multiple checkpoints and data quality was secured by means of automatic validation processes in addition to weekly physicians' roundups.Execution of FaRMI in the form presented is feasible and it will build up a comprehensive population-based registry for MI in the region.
url http://europepmc.org/articles/PMC5132161?pdf=render
work_keys_str_mv AT ehsanbahramali fasaregistryonacutemyocardialinfarctionfarmifeasibilitystudyandpilotphaseresults
AT alirezaaskari fasaregistryonacutemyocardialinfarctionfarmifeasibilitystudyandpilotphaseresults
AT habibzakeri fasaregistryonacutemyocardialinfarctionfarmifeasibilitystudyandpilotphaseresults
AT mojtabafarjam fasaregistryonacutemyocardialinfarctionfarmifeasibilitystudyandpilotphaseresults
AT azizallahdehghan fasaregistryonacutemyocardialinfarctionfarmifeasibilitystudyandpilotphaseresults
AT kazemzendehdel fasaregistryonacutemyocardialinfarctionfarmifeasibilitystudyandpilotphaseresults
_version_ 1725415387828322304